Clinical Trials Browser

Neuroblastoma × 3-Iodobenzylguanidine × 30 days × Clear all

NCT00107289 2026-05-29

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Phase 2 Recruiting

Neuroblastoma, Pheochromocytoma